University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Faculty Publications, Department of Statistics

Statistics, Department of

2013

The change in differing leukocyte populations during vaccination
to bovine respiratory disease and their correlations with lung
scores, health records, and average daily gain
R. J. Leach
ARS-USDA, U.S. Meat Animal Research Center

C. G. Chitko-McKown
ARS-USDA, U.S. Meat Animal Research Center, carol.chitkomckown@ars.usda.gov

G. L. Bennett
ARS-USDA, U.S. Meat Animal Research Center, gary.bennett@ars.usda.gov

S. A. Jones
ARS-USDA, U.S. Meat Animal Research Center

Stephen D. Kachman
University of Nebraska-Lincoln, steve.kachman@unl.edu

See next page for additional authors
Follow this and additional works at: https://digitalcommons.unl.edu/statisticsfacpub
Part of the Other Statistics and Probability Commons

Leach, R. J.; Chitko-McKown, C. G.; Bennett, G. L.; Jones, S. A.; Kachman, Stephen D.; Keele, J. W.;
Leymaster, K. A.; Thallman, R. M.; and Kuehn, L. A., "The change in differing leukocyte populations during
vaccination to bovine respiratory disease and their correlations with lung scores, health records, and
average daily gain" (2013). Faculty Publications, Department of Statistics. 52.
https://digitalcommons.unl.edu/statisticsfacpub/52

This Article is brought to you for free and open access by the Statistics, Department of at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications,
Department of Statistics by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Authors
R. J. Leach, C. G. Chitko-McKown, G. L. Bennett, S. A. Jones, Stephen D. Kachman, J. W. Keele, K. A.
Leymaster, R. M. Thallman, and L. A. Kuehn

This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
statisticsfacpub/52

The change in differing leukocyte populations during vaccination to bovine respiratory
disease and their correlations with lung scores, health records, and average daily gain1,2,3
R. J. Leach,*4 C. G. Chitko-McKown,* G. L. Bennett,* S. A. Jones,*
S. D. Kachman,† J. W. Keele,* K. A. Leymaster,* R. M. Thallman,* and L. A. Kuehn*
*ARS-USDA, U.S. Meat Animal Research Center, Clay Center, NE 68933; and
†Department of Statistics, University of Nebraska–Lincoln, Lincoln 68583

Abstract: Bovine respiratory disease (BRD) is
the most economically important disease in U.S. feedlots. Infection can result in morbidity, mortality, and
reduced average daily gain. Cheap and reliable genetic
methods of prediction and protection from BRD would
be highly advantageous to the industry. The immune
response may correlate with BRD incidence. Cattle (n
= 2,182) were vaccinated against common viral and
bacterial pathogens of BRD. Two blood samples were
collected, one during booster vaccination and one 21d
later, enabling 3 phenotypes for each trait [prebooster
(pre), postbooster (post), and delta (post minus pre)].
From the blood samples innate and adaptive responses
[counts of white blood cells (WBC), neutrophils, lymphocytes, monocytes, eosinophils, and basophils] were
measured. In addition, feedlot ADG and binary traits
[health records (HR; 0 = healthy, 1 = ill) and lung scores
(LS; collected at harvest; 0 = no lesions, 1 = lesions)]
were also recorded. Traits ADG, HR, and LS have all
been significantly correlated with infection to BRD. In
this investigation we aimed to find correlations between
the immune response and ADG, HR, and LS to find an
easily measurable trait that would be a good predictor of
BRD resistance after vaccination. The results showed an

average positive delta for the innate immune response
(eosinophils, basophils, neutrophils), whereas the adaptive immune response had an average negative delta
(lymphocytes). Overall, we discovered that the immune
responses had moderately high heritabilities (h2; lowest:
delta monocytes, 0.21 ± 0.05; greatest: pre lymphocytes: 0.5 ± 0.05), with lymphocytes having the greatest
h2 throughout the study (h2 ≥ 0.41). All genetic correlations were calculated using bivariate REML models.
Although LS did not significantly correlate with any
of the immune phenotypes, both ADG (post lymphocytes, -0.24 ± 0.12) and HR (pre eosinophils, -0.67 ±
0.29; delta WBC, -0.5 ± 0.24, and delta lymphocytes,
-0.67 ± 0.21) did. All the significant genetic correlations
with HR were negative; resistance to BRD appears to
be a function of greater delta lymphocytes and WBC.
The increase in eosinophils may potentially link its role
in decreasing lymphocytes. These results may enable
producers to predict if revaccination, quarantine, and
breeding of animals is required to reduce the incidence
of BRD postvaccination. In addition, immunological
phenotypes maybe used to aid genomic selection indices
to select animals with greater rates of protection after
BRD vaccination.
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Introduction

Bovine respiratory disease (BRD) is the most
costly disease in U.S. beef cattle; infection can result
in morbidity, mortality, and reduced ADG, causing
the value of a carcass to decrease (Irsik et al., 1996;
Griffin, 1997; Fulton, 2009). When treatment is also
considered, costs can increase rapidly (McNeill et al.,
1996; Faber et al., 1999). The estimated heritability of
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BRD is low (Muggli-Cockett et al., 1992; Snowder et
al., 2005; Schneider et al., 2010); however, it is likely underestimated because of field and observational
phenotypes being used (Bishop and Woolliams, 2010).
Because of direct and indirect costs associated with
treating BRD infection, methods to genetically select
or manage animals for increased resistance would be
beneficial. By concentrating on correlated component
traits, methods such as breeding for increased disease
resistance and genetic prediction are possible.
The immune response is highly complex with many
components of both the innate and adaptive responses needed to confer immunity after infection or vaccination. White blood cell counts (WBC) and counts
of white blood cell types (neutrophils, lymphocytes,
monocytes, eosinophils, and basophils) are objective
measures of innate or adaptive immunity. Measurement
of these immune response variables in response to respiratory disease vaccinations could provide an objective measure for the potential of an animal for resistance to BRD.
Lung score (LS), health records (HR), and ADG
have all been used as measures or correlates of BRD
incidence (Wittum et al., 1996; Thompson et al., 2006;
Schneider et al., 2009). Thus, we investigated all 3
for potential genetic correlations with the immune response. Correlated traits would allow us to understand
if the immune response at the end of vaccination is indicative of resistance to BRD or changes in ADG.
Within this study we show that the immune traits
(blood phenotypes) change significantly during the
time course. We also discover significant correlations
between the blood phenotypes and ADG, HR, and LS.
Materials and Methods
Animals were raised in conformation with the
Guide for the Care and Use of Agricultural Animals
in Agricultural Research and Teaching (FASS, 1999),
and their care was approved by the U.S. Meat Animal
Research Center (USMARC) Animal Care and Use
Committee.
Phenotypes were collected from 2,182 cattle born
in 2008, 2009, and 2010 from the USMARC Germ
Plasm Evaluation (GPE) herd. The phenotypes were
measured at 2 time points during vaccination with 2
multipurpose vaccines. The vaccines offered protection against both viral (BRSV, IBR, PI3, BVD I, and
BVD II) and bacterial (such as Pasteurella haemolytica) components of BRD. The measured phenotypes
were the counts, within whole blood, of WBC, neutrophils, lymphocytes, monocytes, eosinophils, and basophils. In addition to the blood-based phenotypes, HR,
LS, and feedlot ADG were also measured.
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Animals and Pedigree
Data were collected from animals in advanced generations of the USMARC GPE herd, Clay Center, Nebraska.
This particular GPE subset was a product of multiple-sire
matings of crossbred cows to F1 bulls of varying halfblood composition. The resulting animals used within this
study consisted of variable fractions of 9 breeds: Angus,
Hereford, Red Angus, Brahman, Charolais, Gelbvieh,
Limousine, Simmental, and MARCIII composite (1/4
Angus, 1/4 Hereford, 1/4 Red Poll, 1/4 Pinzgauer).
As part of a separate project, calves were genotyped for approximately 50,000 SNP markers using the
Illumina BovineSNP50 (Illumina Inc., San Diego, CA).
Resulting genotypes were used to assign sires to their
progeny. By subtracting the genotypes of the candidate
animal with each potential parent (in a stepwise manner), the parent of the candidate animal can be predicted;
smaller values (when all 50,000 SNP differences are
summed) indicate paternity. We excluded paternity if
values were greater than 0.05%. If more than 1 sire was
eligible, the sire with the smallest value was chosen.
Vaccination Schedule
Initial vaccination was at prebreeding (average age =
60 d). The booster vaccination was administered at preconditioning. The average age of the calves at the booster vaccination was 139 d (with a SD of 17 d).
All animals were vaccinated in accordance with the
manufacturer’s guidelines. Each animal was administered 2 mL intramuscularly (for both initial and booster
vaccinations) of Merck Vista 5 SQ and Vista Once SQ
(years 2008 and 2009; Merck Inc., Summit, NJ) or Pfizer
Bovi-Shield Gold 5 and One Shot Ultra 8 (animals born
in 2010; Pfizer Inc., New York, NY). The vaccines used
offered protection from common viral and bacterial
components that cause BRD. Only One Shot Ultra 8
contained an adjuvant, Stimugen (Pfizer Inc.).
Phenotypes
Binary Traits. Both HR and LS were analyzed as binary threshold traits. The HR were collected from weaning
(165 ± 17 d) to slaughter. The monitoring period for BRD
began when animals were weaned into the USMARC
feedlot 21 d after the booster vaccination. Animals were
not given therapeutic antibiotics during the feeding period, unless there was an outbreak situation. All animals
were monitored for respiratory disease and illness by
trained cattlemen; cattle were diagnosed on the basis of
the observation of multiple symptoms, including lethargy,
nasal discharge, isolation from other animals, respiration
rate, and body temperature (after being removed from pen
for treatment). Cattle not diagnosed with BRD-like symp-
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toms between vaccination and slaughter were coded as 0
for analysis. Cattle that had symptoms sufficient for BRD
diagnosis postweaning were assigned a 1.
Lung scores were conducted by observing the percentage of the lung surface containing lung lesions postmortem
(similar to the system designed by D. Griffin, University
of Nebraska–Lincoln, personal communication). Briefly,
lungs were inspected visually at an abattoir at line speed
(~360 carcasses/h) by a veterinarian trained to observe lung
lesions. Although lungs were scored on a multipoint scale
depending on severity (percent of lung with lesions), preliminary analyses showed no additional information was
garnered by analyzing the multinomial scale. Therefore, all
animals with any lung lesions were coded as a 1, whereas
animals with no lesions present were coded as 0.
Average Daily Body Weight Gain. The ADG was calculated as the linear regression coefficient of BW on age of
the animal at multiple time points (at least 3 time points for
each animal) from weaning through final (preharvest) BW.
Blood Collection and Blood Analysis. Initial blood
samples (25 mL) were collected concurrently with the
administration of the first booster vaccination at preconditioning. A second blood sample (25 mL) was collected
21 d later at weaning. Whole blood was collected by
jugular venipuncture, and 1 mL was deposited into 2-mL
screw cap tubes containing potassium EDTA as an anticoagulant. Before analysis on a Hemavet CDC Mascot
veterinary hematology analyzer (CDC Technologies,
Oxford, CT), the samples were brought to room temperature and stirred for at least 15 min. Data from the analyses were transferred to spreadsheets using WinWedge
Pro software (Taltech Inc., Philadelphia, PA). Delta
measurements were obtained from the subtraction of
the prebooster phenotypes from the postbooster phenotypes. Measurements of WBC, neutrophils, lymphocytes,
monocytes, eosinophils, and basophils were used as phenotypes (all measured in k/μL). Red blood cell phenotypes were also measured but not used as an indicator of
immune function.
Statistical Analysis
Software (ASREML; Gilmour et al., 2009) was used
for REML estimates of all (co)variance components.
Heritability for each trait was estimated using a univariate REML model. For all traits, the model included birth
location and mating group by year of birth (CG) and sex
(S) as fixed effects; β1, the linear regression on the expected level of heterosis h (heterosis: min = 0, max = 1,
average = 0.78); β2, the linear regression on birth date
b; a, the random effect of animal, a ~ N(0, Aσ2g), where
A is the numerator relationship matrix; and eijk, the residual error, e ~ N(0, Iσ2p):

Table 1. Means and SD of traits measured pre- and postbooster vaccination and the changes between them (delta)
Prebooster
Postbooster
Delta
Trait1
Mean
SD
Mean
SD
Mean
SD
WBC
10.44
2.76
10.39
2.24
-0.04
2.76
NE*
2.89
1.25
3.03
1.16
0.15
1.42
LY*
5.97
1.74
5.5
1.34
-0.47
1.54
MO
0.65
0.27
0.64
0.23
0
0.30
EO*
0.89
0.50
1.15
0.60
0.26
0.67
BA*
0.04
0.05
0.07
0.09
0.03
0.10
1Traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY),
monocytes (MO), eosinophils (EO), and basophils (BA). An asterisk (*) next
to the trait name indicates that the pre- and postbooster phenotype measurements are significantly different (P < 0.01).

Yijk = µ + CGi + Sj + β1h + β2b + ak + eijk.
Breed composition was included in the model using genetic founder group effects (Westell et al., 1988).
Bivariate REML models were used to calculate the genetic correlations between ADG, HR, and LS with the
blood phenotypes. Because of the binary nature of HR
and LS, a probit link function was used; to estimate the
genetic correlation of these 2 traits, 1 of the 2 variables
was fitted as linear. As results did not vary on the basis
of which trait was linear, we show results from fitting LS
as linear. The same fixed effects were fitted in bivariate
models and univariate models. Relationships among the
delta measurements were derived using a 6-trait multivariate model. A t test using the SE of the correlation coefficient was used to calculate the correlation P-values.
Results
Trait Overview
The blood phenotypes are summarized in Table 1,
with “pre” phenotypes highlighting concentrations at
the point of booster vaccination and “post” phenotypes
highlighting concentrations at 21 d after booster vaccination. Although the delta measurements (post phenotype minus pre phenotype; Table 1) are small and even
negative (with 2 of the 6 showing a decrease), t tests
show highly significant differences between pre vs. post
(P < 0.01), with the exceptions of WBC and monocytes,
which were not significant (P > 0.05). Average ADG
was 3.15 (SD = 0.49), whereas HR and LS had averages
of 0.13 and 0.79, respectively.
Table 2 shows the means for each blood phenotype
measure relative to HR and LS. All the phenotypes that
are significantly different for HR are also significantly
different when grouped by lung score (pre and delta
lymphocytes and pre and post basophils; Table 2). In addition, the concentrations of pre WBC and delta WBC
are also significantly different between the groupings of
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Table 2. Mean and standard deviation for blood phenotypes measured pre- and postbooster vaccination and the
changes between them (delta) when separated by health record and lung score categories
Health Records
Lung Score
Trait1
02
SD3
14
SD
0 vs. 15
0
SD
1
SD
0 vs. 1
Pre_WBC
10.40 (1,882)
2.83
10.68 (277)
2.24
10.67 (429)
2.16
10.32 (1,573)
2.95
<0.01
Post_WBC
10.43 (1,887)
2.25
10.19 (283)
2.15
10.38 (432)
2.32
10.43 (1,584)
2.12
Delta_WBC
0.06 (1,897)
3.06
-0.27 (284)
2.89
-0.22 (433)
2.42
0.19 (1,590)
3.43
<0.01
Pre_NE
2.88 (1,882)
1.25
2.93 (277)
1.23
2.89 (429)
1.16
2.88 (1,573)
1.39
Post_NE
3.05 (1,887)
1.15
2.94 (283)
1.19
3.01 (432)
1.20
3.05 (1,584)
1.09
Delta_NE
0.17 (1,897)
1.47
0.07 (284)
1.40
0.14 (433)
1.33
0.19 (1,590)
1.61
Pre_LY
5.93 (1,882)
1.76
6.22 (277)
1.57
<0.01
6.24 (429)
1.47
5.89 (1,573)
1.67
<0.01
Post_LY
5.51 (1,887)
1.34
5.46 (283)
1.37
5.54 (432)
1.36
5.50 (1,584)
1.25
Delta_LY
-0.40 (1,897)
1.71
-0.63 (284)
1.64
<0.05
-0.65 (433)
1.39
-0.35 (1,590)
1.64
<0.01
Pre_MO
0.65 (1,882)
0.27
0.63 (277)
0.22
0.62 (429)
0.22
0.64 (1,573)
0.32
Post_MO
0.64 (1,887)
0.23
0.64 (283)
0.22
0.63 (432)
0.22
0.65 (1,584)
0.22
Delta_MO
0.00 (1,897)
0.31
0.02 (284)
0.29
0.01 (433)
0.24
0.02 (1,590)
0.40
Pre_EO
0.90 (1,882)
0.50
0.87 (277)
0.48
0.88 (429)
0.39
0.86 (1,573)
0.64
Post_EO
1.15 (1,887)
0.61
1.09 (283)
0.54
1.14 (432)
0.58
1.16 (1,584)
0.56
Delta_EO
0.26 (1,897)
0.68
0.24 (284)
0.62
0.26 (433)
0.60
0.30 (1,590)
0.79
Pre_BA
0.042 (1,882)
0.06
0.035 (277)
0.03
<0.01
0.03 (429)
0.04
0.04 (1,573)
0.09
<0.05
Post_BA
0.07 (1,887)
0.09
0.06 (283)
0.07
<0.05
0.06 (432)
0.08
0.07 (1,584)
0.07
<0.05
Delta_BA
0.03 (1,897)
0.10
0.02 (284)
0.07
0.03 (433)
0.08
0.03 (1,590)
0.10
1All names have been standardized. Abbreviations of traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY), monocytes (MO), eosinophils
(EO), and basophils (BA), where pre_ = trait measured when booster vaccinations were administered, post_ = trait measured 21 d after booster vaccinations, and
delta_ = post time point minus pre time point.
2Here 0 = the mean average of all animals with a 0 for diagnosis (animal remained healthy after vaccination) or lung lesion (no damage to lung). The number
in parentheses is the number of animals used to make the observation.
3The SD of the measured trait.
4Here 1 = the mean average of all animals with a 1 for diagnosis (animal diagnosed with respiratory illness after vaccination) or lung lesion (damage to lung).
The number in parentheses is the number of animals used to make the observation.
5Here 0 vs. 1 = P-value from a 2-tailed t test between 0 and 1 of diagnosis or lung lesion. If no value is entered, P > 0.05.

lung scores (Table 2). The counts for each phenotype,
split by HR and lung score, are also shown in Table 2,
where the minimum count for HR was 227 (HR = 1, pre
phenotypes). The minimum count for lung score was
429 (lung score = 0, pre phenotypes).
The counts for the 2 binary traits combined are shown
in Table 3. It would appear that the diagnosis of a healthy
animal with no BRD was accurate during this study.
Accordingly, 86.1% of animals that did not have lung lesions had no previous diagnosis. Indeed, of those diagnosed, 76.5% had lung lesions. However, the specificity
of the lung lesions as a measure of clinical BRD symptoms appeared low, as animals with lung lesions generally
had no diagnosis records (87.7%, Table 3). The 2 traits
(LS and HR) are very poor predictors of each other.
Heritability
Heritability was calculated for each blood phenotype
as well as ADG, HR, and LS (Table 4). A wide range
of heritabilities was observed in this study (Table 4).
The greatest heritability estimated for the pre, post, and
delta phenotypes was pre lymphocytes [h2 = 0.5 (0.07);
Table 4], whereas the smallest was delta monocytes [h2 =

0.21 (0.05); Table 4]. The concentration of lymphocytes
in the whole blood appears to be the most consistently
heritable phenotype measured throughout the booster
vaccination. Its heritability was estimated above 0.4 for
the pre, post, and delta phenotypes. In general, heritability
is lower for the delta phenotypes. Lung score and HR both
had low heritabilities (h2 for both <0.1; Table 4), whereas
ADG had a moderately high heritability [h2 = 0.44 (0.07)].
Genetic Correlations
To discover the role of the additive genetic variation
in maintaining increased concentrations of the blood
phenotypes during the booster, genetic correlations
were calculated between the pre and post phenotypes
(Table 5). All of the correlations, with the exception of
Table 3. Counts of the number of animals with different
lung scores cross classified with health records
Health Records
0
1
Total

0
373
60
433

Lung Score
1
1395
195
1590

Total
1,768
255
2,023
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Table 4. Heritabilities and additive variance for blood phenotypes measured pre- and postbooster vaccination and the
changes between them (delta) and ADG, health records, and lung scores
Prebooster
Postbooster
Delta
Trait1
h2
SE
Add_Var2
SE
h2
SE
Add_Var
SE
h2
SE
Add_Var
SE
WBC
0.47
0.06
3.28
0.52
0.47
0.07
2.28
0.38
0.35
0.06
2.34
0.43
NE
0.44
0.06
0.68
0.11
0.41
0.06
0.55
0.1
0.24
0.05
0.47
0.11
LY
0.50
0.07
1.21
0.19
0.45
0.06
0.74
0.12
0.41
0.06
0.76
0.13
MO
0.28
0.06
0.02
0.00
0.39
0.07
0.02
0.00
0.21
0.05
0.02
0.00
EO
0.45
0.07
0.10
0.02
0.42
0.06
0.14
0.02
0.38
0.06
0.16
0.03
BA
0.23
0.06
0.001
<0.001
0.25
0.06
0.002
<0.001
0.25
0.06
0.002
<0.001
ADG3
0.44
0.07
0.08
0.01
Health records3
0.07
0.05
0.08
0.06
Lung score3
0.06
0.04
0.07
0.05
1Traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY), monocytes (MO), eosinophils (EO), and basophils (BA).
2Add_Var = additive variance for each trait.
3The delta measurement was not used for ADG, diagnosis, and lung score. These were measured at differing time points, as discussed in the Materials and
Methods section.

basophils, differed from 0 (P < 0.05). The 3 greatest correlations of WBC, neutrophils, and lymphocytes (0.64 ±
0.07, 0.73 ± 0.08, and 0.67 ± 0.06, respectively; Table 5)
were highly significant (P < 0.01). Although the average
WBC and the lymphocytes delta measurements are negative, they show positive genetic correlations between
the pre and post measurements (Tables 1 and 5).
Genetic correlations were estimated (Table 6) between all of the blood phenotypes with ADG, HR, and
LS. Of the estimated correlations, 4 were significant
(t test; P < 0.05; Table 6). The majority of phenotypes (with the exceptions of pre neutrophils, post eosinophils, delta monocytes, delta eosinophils, and HR)
were negatively correlated with ADG. However, the
only 1 of these correlations that was significant was
between ADG and post lymphocytes (-0.24 ± 0.12), indicating that ADG decreased as post lymphocytes concentrations increased. No significant correlations existed between any blood phenotype and LS. However,
3 phenotypes were significantly correlated with HR
(pre eosinophils, delta WBC, and delta lymphocytes;
Table 6). The greatest correlation was significant with a
P-value of less than 0.01 (delta lymphocytes), whereas
Table 5. Genetic correlations of pre- and postbooster
vaccination measurements of blood phenotypes
Trait1
SE
Pre vs. post r2
WBC
0.65***
0.07
NE
0.72***
0.08
LY
0.67***
0.06
MO
0.39*
0.15
EO
0.27*
0.12
BA
-0.12
0.20
1Traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY),
monocytes (MO), eosinophils (EO), and basophils (BA).
2Pre vs. post r = genetic correlation between the prebooster and postbooster trait. *P < 0.05; ***P < 0.001.

the other 2 had P-values of 0.05 or better (pre eosinophils, delta WBC).
When compared, the genetic correlations of the phenotypes with HR vs. with LS have little similarity. Ten
of the 18 correlations calculated did not change direction when the same trait was correlated with HR as opposed to LS (Table 6). However, large SE are present,
and little genetic correlation exists between the 2 binary
traits (0.16 ± 0.6; Table 6), highlighting the differing
magnitudes of correlation between the measured phenotypes and the 2 binary traits.
Genetic correlations of the delta blood phenotypes
are summarized in Table 7. In general, the blood phenotypes were highly correlated, with 10 of the 15 possible correlations being significant (P < 0.05). With the
exception of basophils vs. neutrophils and lymphocytes,
all of the significant correlations were positive.
Breed Differences
The models used during this study estimated the effects of each breed in the GPE herd. All breeds showed
similar effects throughout the study (Table 8), with few
being significantly different from the others for any trait.
A notable exception is the Bos indicus breed, Brahman,
which was significantly different from the other breeds
throughout various phenotypes. From all the breeds that
compose the GPE herd, Brahman and Hereford elicited
significantly different phenotypes the most frequently.
No other breeds were significantly different from each
other. In addition, the results indicated that no breed had
a significant effect on ADG, diagnosis, or lung lesion.
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Table 6. Genetic correlations of blood phenotypes preand postbooster vaccination and the changes between
them (delta) with ADG, health records, and lung score
ADG
Trait1
SE
r
Pre_WBC
-0.05
0.12
Post_WBC
-0.20
0.12
Delta_WBC -0.14
0.13
Pre_NE
0.04
0.13
Post_NE
-0.10
0.13
Delta_NE
-0.20
0.16
Pre_LY
-0.08
0.12
Post_LY
-0.24*
0.12
Delta_LY
-0.12
0.12
Pre_MO
-0.17
0.17
Post_MO
-0.10
0.14
Delta_MO
0.00
0.16
Pre_EO
-0.08
0.13
Post_EO
0.00
0.13
Delta_EO
0.05
0.13
Pre_BA
-0.04
0.18
Post_BA
-0.05
0.15
Delta_BA
-0.04
0.15
Lung score
-0.15
0.33
Diagnosis
0.25
0.27
*P < 0.05; **P < 0.01.

Health record
SE
r
0.10
0.26
-0.44
0.24
-0.50*
0.24
-0.36
0.28
-0.52
0.27
-0.16
0.33
0.48
0.25
-0.26
0.23
-0.67** 0.21
-0.33
0.33
-0.14
0.28
0.12
0.32
-0.67*
0.29
-0.23
0.27
0.16
0.27
-0.14
0.35
0.33
0.3
-0.23
0.27
0.16
0.59

Lung score
SE
0.32
0.31
0.34
0.32
0.31
0.39
0.32
0.35
0.3
0.45
0.33
0.37
0.33
0.32
0.34
0.43
0.36
0.37

r
0.20
0.19
-0.06
0.10
-0.19
-0.28
0.21
0.56
0.22
0.36
0.50
0.29
-0.03
-0.38
-0.39
-0.22
-0.64
-0.52

1Traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY),
monocytes (MO), eosinophils (EO), and basophils (BA), where pre_ = trait
measured when booster vaccinations were administered, post_ = trait measured 21 d after booster vaccinations, and delta_ = post time point minus pre
time point.

Discussion
This investigation aimed to discover correlates of
immunity significantly associated with BRD incidence.
Discovering correlates affecting BRD incidence after
vaccination has the potential to help producers alter vaccination schedules, isolate animals that are vulnerable to
infection, and, most importantly, reduce the incidence of
BRD in a herd by providing heritable targets for genetic
and, eventually, genomic selection. Further, by defining
accurate immunological phenotypes, vaccinologists may,
in turn, be able to design vaccines that benefit weak responders by investigating the immune responses of successfully immunized animals. This investigation monitored the immune response of a herd of crossbred cattle
during the final stage of vaccination to both viral and bacterial causes of BRD. The immune response, as measured
by counts of white blood cell populations, was found to
be highly variable and heritable during this period, which
has been highlighted in different herds using different
vaccines/immunizations and phenotypes (Kalina et al.,
2005; Leach et al., 2010, 2012). Using genetic models to
attribute the phenotypic variation to genetic components
has enabled this study to suggest possible correlates to
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Table 7. Genetic correlations1 between changes in (delta)
blood phenotype pre- and postbooster vaccination
Delta blood phenotypes
Delta blood
phenotypes2 WBC
NE
LY
MO
EO
BA
WBC
0.05
0.04
0.13
0.10
0.15
NE
0.86***
0.11
0.19
0.15
0.18
LY
0.86*** 0.75***
0.14
0.12
0.12
MO
0.37** -0.05
0.09
0.08
0.12
EO
0.43*** 0.17
-0.05
0.87***
0.06
BA
-0.10
-0.36*
-0.48*** 0.71*** 0.81***
1Below the diagonal shows the genetic correlation coefficient; above the
diagonal shows the SE. t tests were conducted to obtain P-values (*P < 0.05;
**P < 0.01; ***P < 0.001).
2The blood phenotypes are white blood cells (WBC), neutrophils (NE),
lymphocytes (LY), monocytes (MO), eosinophils (EO), and basophils (BA).

immune responses, which may allow selection for animals that are more resistant to BRD after vaccination.
Both the innate and the adaptive immune responses
play a role in vaccination to ensure that a long-lasting
immunologic memory is formed. Although the immune
response variables measured in the current study were
nonspecific to the vaccines used, they do highlight the
processes of the immune system during vaccination to
BRD. Further, as similar response profiles were recorded each year of vaccination, the results suggest that the
responses observed during this study were elicited by
the vaccines used.
The innate immune system has evolved to target
and remove bacterial and viral pathogens. Detection of
such pathogens, within the innate immune system, is
nonspecific. Thus, cells of the innate immune system
have evolved receptors such as pathogen recognition
receptors to detect pathogen-associated molecular patterns (Werling and Jungi, 2003; Akira et al., 2006) and
Fc receptors to detect antibody-bound viral and bacterial particles (Janeway et al., 2005). Three cell types of
the polymorphonuclear cell family, which contribute to
the innate immune response, were measured in the current study (neutrophils, basophils, and eosinophils). All
3 cell types contain receptors to interact with specific
antibody isotypes and cytokines released during an immune response (Paape et al., 2003; Ackermann et al.,
2010; Tizard, 2012). A significant increase in these cell
types was observed in our results after BRD vaccination. Thus, although the lymphocytes response was on
average declining, parts of the innate immune system
were still increasing. As the half-life of granulocytes is
relatively short (Carlson and Kaneko, 1975) and neutrophils are a swift-acting part of the innate immune
response, often migrating to the location of infection
within 1 h to engage with bacterial pathogens (Paape et
al., 2003), we suggest that these cell types were actively
engaging either one or both of the vaccines. In addition,
a review of the current literature in humans has shown
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Table 8. Predicted breed means for each of the blood phenotypes pre- and postbooster vaccination and the changes
between them (delta), ADG, lung score, and health records1
Trait2
Angus SE Hereford SE Red Angus SE Brahman SE Charolais SE Gelbvieh SE Limousin SE Simmental SE
Pre_WBC 10.66
1.74 10.52
1.70
12.11
1.66 11.07
2.68
12.45
1.75 11.41
1.73
11.73
1.69
10.03
1.78
Post_WBC 10.25
1.46
9.28
1.43
10.44
1.39 11.96
2.24
11.19
1.46 10.91
1.45
10.52
1.42
9.93
1.50
Delta_WBC -0.59
1.68 -1.39
1.64
-1.77
1.61
0.29
2.49
-1.32
1.69 -0.59
1.67
-1.32
1.64
-0.14
1.72
Pre_NE
2.93
0.81
2.68
0.80
3.13
0.78
2.25
1.24
3.48
0.82
3.15
0.81
2.45
0.79
3.31
0.83
Post_NE
2.63
0.76
2.77
0.74
3.24
0.72
2.45
1.15
2.92
0.76
3.62
0.75
2.36
0.74
3.29
0.78
Delta_NE
-0.29
0.89
0.08
0.87
0.16
0.85
-0.05
1.27
-0.44
0.90
0.47
0.89
-0.04
0.87
0.10
0.91
Pre_LY
5.73
1.02
6.24
1.00
6.71
0.98
7.11
1.59
6.66
1.03
6.49
1.02
7.40
1.00
5.22
1.05
Post_LY
4.97
0.84
4.64
0.82
4.89
0.80
5.31
1.29
5.50
0.84
4.54
0.83
5.77
0.82
4.15
0.86
Delta_LY
-0.82
0.89 -1.68
0.87
-1.89
0.85
-1.94
1.35
-1.22
0.90 -1.97
0.89
-1.70
0.87
-1.10
0.92
Pre_MO
0.68
0.16
0.60
0.16
0.80
0.15
0.79
0.23
0.64
0.16
0.45
0.16
0.71
0.16
0.42
0.16
Post_MO
0.65
0.14
0.46
0.14
0.51
0.14
0.81
0.22
0.50
0.15
0.45
0.14
0.54
0.14
0.34
0.15
Delta_MO -0.07
0.18 -0.16
0.17
-0.31
0.17
-0.02
0.25
-0.16
0.18 -0.01
0.18
-0.18
0.17
-0.09
0.18
Pre_EO
1.33
0.31
0.98
0.30
1.40
0.29
0.88
0.47
1.61
0.31
1.34
0.30
1.14
0.30
1.10
0.31
Post_EO
1.88ab 0.38
1.36a
0.37
1.67ab 0.36
2.95b 0.58
2.17ab 0.38
2.14ab 0.38
1.75ab 0.37
2.01ab 0.39
Delta_EO
0.51a 0.42
0.35a
0.41
0.25a
0.40
2.00b 0.63
0.53ab 0.42
0.77ab 0.42
0.58ab 0.41
0.88ab 0.43
Pre_BA
0.07
0.03
0.04
0.03
0.07
0.03
0.06
0.05
0.07
0.03
0.04
0.03
0.05
0.03
0.02
0.03
0.06a
0.05
0.09a
0.05
0.32b 0.08
0.11a
0.06
0.12a
0.06
0.10a
0.05
0.14ab 0.06
Post_BA
0.11a 0.06
Delta_BA
0.04a 0.06
0.02a
0.06
0.02a
0.06
0.26b 0.09
0.03a
0.06
0.08ab 0.06
0.05a
0.06
0.11ab
0.06
ADG
3.58
0.46
3.72
0.45
3.76
0.45
3.11
0.55
3.47
0.46
3.43
0.46
3.52
0.45
3.57
0.46
Diagnosis
-3.58
1.23 -2.10
1.15
-3.05
1.18 –4.70
1.52
-3.44
1.23 -3.23
1.20
-2.95
1.18
-3.13
1.21
Lung Score 2.12
1.03
1.19
0.93
0.30
0.92
0.60
1.14
1.03
0.97
1.26
0.95
0.85
0.93
0.70
0.96
1Within a row means with different superscripts are different (P < 0.05).
2The traits are white blood cells (WBC), neutrophils (NE), lymphocytes (LY), monocytes (MO), eosinophils (EO), and basophils (BA), where pre_ = trait
measured when booster vaccinations were administered, post_ = trait measured 21 d after booster vaccinations, and delta_ = post time point minus pre time point.

that eosinophils also play an active role in modulating
a Th2-mediated response (Kita, 2011). There is a close
resemblance between the bovine and human immune
responses (Goddeeris, 1998). Thus, a similar role may
be occurring within the current study, with eosinophils
having an active part in modulating the role of the lymphocytes during this immune response.
The average decrease in the lymphocytes suggests
that the adaptive immune response to the vaccines was
declining by the second time point, having had ample
time to produce a response with the possibility of immunological memory. However, when investigating
the additive genetic correlation between pre and post
phenotypes, lymphocytes showed a significant positive
correlation. Several animals did increase or maintain
lymphocytes concentrations throughout both measurements. These animals may be allocating more resources to immune function (negative correlation with
ADG) and are likely less susceptible to BRD (based on
negative HR correlation) after vaccination.
Estimates of heritability for BRD infection (using
HR or LS) remain low (Muggli-Cockett et al., 1992;
Snowder et al., 2005). The low estimates are largely
caused by the phenotypes used to record BRD incidence. Bishop and Woolliams (2010) have shown that
heritability may be underestimated because broad-based
phenotypes (such as the binary traits used in the cur-

rent study) cannot account for all the different types of
pathogens that cause infection. Additionally, there are
often errors in coding healthy animals as diseased and
diseased animals as healthy. Both misclassifications severely impact the heritability estimated from diagnoses.
Indeed, the outcome of this study has also shown low
estimates of heritability (0.06 and 0.07 for LS and HR,
respectively). The immune response phenotypes were
estimated to have much higher heritabilities. However,
these responses were measured very accurately during a
short time frame (during vaccination, which should elicit an immune response). The higher heritabilities and the
magnitude of their genetic correlation with HR suggest
these blood phenotypes could be candidates for indicator
traits in genetic and genomic evaluations.
During this investigation we aimed to identify
measurable immunological phenotypes that significantly changed during vaccination and had a positive
effect on BRD incidence. A method we chose to do this
tested for significant genetic correlates of ADG, HR
(until slaughter), and LS (at harvest) with the immune
responses measured.
Although measuring the LS at harvest maybe cost
and labor prohibitive, correlations have been reported
between lung ultrasonography and respiratory disease
in cattle (Rabeling et al., 1998; Flock, 2004). Thus, the
use of ultrasonography to detect lung lesions in cattle

White blood cell correlations to respiratory disease

to identify either current or previous interactions with
a BRD pathogen is possible. Unfortunately, no significant correlation existed between the lung lesions and the
immune responses in this study, suggesting the immune
response measures in this study are poor predictors of
the propensity of cattle to have long-term lung damage.
Many reasons could account for the unexpected nonsignificant correlation. In the current study, the immune
response was only measured for a relatively short time
course containing only 2 time points. Thus, the change
in the immune response may occur before or after the
booster vaccination. Another possibility highlights the
specificity of the immune phenotypes measured. In the
current study, broad blood-based components of both the
innate and adaptive immune responses were measured. If
a more targeted phenotype (e.g., alveolar macrophages)
that plays a role in BRD detection, and possibly pathology, within the lungs (Ackermann et al., 2010) were used,
a significant correlation might have become apparent.
The current study found no evidence of a significant
correlation between lung lesion and BRD incidence. An
issue with the correlation appears to be the crossover
between the distributions. For example, 76% of the animals that were diagnosed did indeed have lesions in the
lung, which indicates a premise for correlation. However,
87% of animals that had lung lesions were diagnosed
as healthy (with respect to BRD). Other studies have
shown similar trends with a large number of untreated
animals also having lung lesions (38% to 68%;Wittum
et al., 1996; Bryant et al., 1999; Thompson et al., 2006;
Schneider et al., 2009); however, the percentage we
present is considerably greater. Much of the error may
have come from the method used to record lung lesions.
Other studies used specific areas of the lung to calculate lung lesions. They also used discrete rather than
binomial distributions, enabling more power to detect
correlations with health trait records. Unfortunately, the
current study did not because of the speed required to
record lung lesions on a large number of animals. Thus,
because of the lack of specificity and the overall trait
type (which has low heritability), detecting significant
genetic correlation using the techniques outlined in this
investigation would require many more animals.
The delta responses of the WBC and lymphocytes
were negatively correlated with HR. Thus, selection to
increase lymphocytes and WBC deltas should improve
BRD health overall after vaccination. The results also
showed that animals genetically predisposed to have
greater pre lymphocytes concentrations had a greater
probability of remaining healthy with respect to BRD.
Thus, the successful immunization of animals (within
this herd) appears to be a function of a greater concentration of pre lymphocytes and a low rate of decline (or no
decline) of WBC and lymphocytes 21 d after the booster
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vaccination is administered. Potentially, a function of
these phenotypes could be used to segregate successfully vaccinated animals from those that need further
vaccination or quarantine. Further, breeding programs
may be able to add these phenotypes to breeding indices
to reduce the overall incidence of BRD within a herd or
as target traits in genomic selection given the reduced
efficacy of using HR alone.
Producing a delta measurement of lymphocytes (or
any of the blood phenotypes used in the current study)
requires a significant amount of time, resources, and
equipment to accurately quantify cell-type concentrations from blood collected from animals at booster vaccination and 21 d later. With the use of modern genomics this phenotype might not need to be measured every
generation (Hayes et al., 2009). If animals are genotyped, markers in the genome can be tested for significant associations with phenotypes (delta lymphocytes in
this instance). As a result, selection of favorable cattle
in subsequent generations could occur at birth, vastly
speeding up generation intervals. We believe that genomic selection shown in the dairy industry (Hayes et
al., 2009) would also apply to selection of cattle that respond to vaccines with perceived immunity. Thus, the
money spent collecting highly heritable and correlated
indicator phenotypes, such as these, would be a valuable
investment into the genomic advancement of a herd, reducing the incidence of BRD post vaccination.
Many studies have shown a negative correlation between animals that are “infected with” or “treated for”
BRD and ADG even during treatment (Bateman et al.,
1990; Jim et al., 1993; Wittum et al., 1996; Thompson
et al., 2006; Schneider et al., 2009). The current study,
however, discovered the opposite, an insignificant correlation between BRD and ADG. It is likely this relationship depends on the level of BRD affecting the herd;
under high challenge, increased immune function may
divert energy from growth. Indeed, the current study did
have many negative correlations with ADG; however,
the only significantly negative correlation was estimated
between post lymphocytes and ADG, thereby indicating
that as the number of lymphocytes increases, the ADG
decreases. Thus, the animals within the herd may have
been diverting energy from growth to eliciting immune
responses. This will have a negative impact on cost of
production (as number of days fed to slaughter will increase). However, from these results we suggest the
possibility that any immune response may reduce ADG
(nonspecific immune responses were measured during
the current study); thus, an immune response elicited
from a vaccine at a controlled time point and at a controlled dose should give animals the best possible chance
to form immunological memory and minimally affect
ADG. Also, the prevalence in the beef industry suggests
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that this lower genetic potential for ADG may be a fair
compromise. Further, changes in the age of vaccination
may potentially alter the negative correlation. In addition,
it appears that HR and, to a lesser extent LS, may be used
as a diagnostic tool. For example, the use of the delta
lymphocyte phenotype as a correlate for later health relative to BRD may enable producers to target animals that
may have responded to BRD vaccination poorly.
The immune response to infection is variable between breeds (Morris, 2007). Further, breed analysis of
the incidence of BRD has shown some significant differences between breeds (Snowder et al., 2006). Within
the current study the results indicated 1 major difference
among the breeds. Brahman was significantly different
from all other breeds for at least 1 phenotype, with the
exception of Simmental. Thus, the major difference appears to be in the differential way a Bos taurus animal
elicits an immune response compared with a Bos indicus–cross animal. Each significant difference in breed
response shows the Brahman breed eliciting a greater response. Further research with more Bos indicus breeds
(the current study contains only 1) is needed to further
validate the differences between the 2 subspecies using
these immune variables. However, our results do indicate that animals with a greater number of eosinophils
(which was significantly different between breeds) are
treated less commonly for BRD post vaccination. Thus,
the significant differences between Bos taurus and
Bos indicus may indicate how a favorable immune response is elicited in cattle. These results may also be
due to breed-specific heterosis (i.e., greater heterosis
for Bos indicus crosses) rather than a strict breed effect.
However, this herd is not ideal for picking out breedspecific differences as the majority of animals contained
within are only a quarter to a half of any 1 breed. This
makes breed comparisons difficult and may explain why
ADG was very similar across the multiple breeds.
Much is still unknown about the genetic effects behind the immune response. In this investigation we have
added to the growing body of research that is currently
investigating the genetic effects behind successful vaccination for BRD. We have shown a significant genetic
correlation of eosinophils count before booster vaccination with HR after vaccination. We have also shown that
changes in WBC and lymphocyte concentrations during
the booster phase of vaccination are correlated with the
ongoing health of an animal and the potential for genetic
selection based on immune response. Further, we have
shown that components of the innate immune response
appear to be actively increasing during the booster phase,
and this also correlates with the health of the animal.

LITERATURE CITED
Ackermann, M. R., R. Derscheid, and J. A. Roth. 2010. Innate immunology of bovine respiratory disease. Vet. Clin. North Am.
Food Anim. Pract. 26:215–228.
Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition
and innate immunity. Cell 124:783–801.
Bateman, K. G., S. W. Martin, P. E. Shewen, and P. I. Menzies. 1990.
An evaluation of antimicrobial therapy for undifferentiated bovine respiratory disease. Can. Vet. J. 31:689–696.
Bishop, S. C., and J. A. Woolliams. 2010. On the genetic interpretation of disease data. PLoS ONE 5:E8940.
Bryant, L. K., L. J. Perino, D. Griffin, A. R. Doster, and T. E. Wittum.
1999. A method for recording pulmonary lesions of beef calves
at slaughter, and the association of lesions with average daily
gain. Bovine Pract. 33:163–173.
Carlson, G. P., and J. J. Kaneko. 1975. Intravascular granulocyte kinetics in developing calves. Am. J. Vet. Res. 36:421–425.
Faber, R., N. Hartwig, W. D. Busby, and R. BreDahl. 1999. The costs
and predictive factors of bovine respiratory disease in standardized steer tests. A.S. Leaflet R1648. 1999 Beef Res. Rep. Iowa
State Univ., Ames.
FASS. 1999. Guide for the Care and Use of Agricultural Animals in
Agricultural Research and Teaching. 1st rev. ed. Fed. Anim. Sci.
Soc., Savoy, IL.
Flock, M. 2004. Diagnostic ultrasonography in cattle with thoracic
disease. Vet. J. 167:272–280.
Fulton, R. W. 2009. Bovine respiratory disease research (1983–2009).
Anim. Health Res. Rev. 10:131–139.
Gilmour, A. R., B. J. Gogel, B. R. Cullis, and R. Thompson.
2009. ASReml user guide release 3.0. VSN Int. Ltd., Hemel
Hempstead, UK.
Goddeeris, B. M. 1998. Handbook of vertebrate immunology.
Academic, San Diego, CA.
Griffin, D. 1997. Economic impact associated with respiratory disease in beef cattle. Vet. Clin. North Am. Food Anim. Pract.
13:367–377.
Hayes, B. J., P. J. Bowman, A. J. Chamberlain, and M. E. Goddard.
2009. Invited review: Genomic selection in dairy cattle:
Progress and challenges. J. Dairy Sci. 92:433–443.
Irsik, M., M. Langemeier, T. Schroeder, M. Spire, and J. D. Roder.
1996. Estimating the effects of animal health on the performance of feedlot cattle. Bovine Pract. 40:65–74.
Janeway, C., P. Travers, M. Walport, and M. Sholmchik. 2005.
Immunobiology. 6th ed. Garland Science Publ., New York, NY.
Jim, G. K., C. W. Booker, C. S. Ribble, P. T. Guichon, and B. E.
Thorlakson. 1993. A field investigation of the economic impact
of respiratory disease in feedlot calves. Can. Vet. J. 34:668–673.
Kalina, W. V., A. R. Woolums, and L. J. Gershwin. 2005. Formalininactivated bovine RSV vaccine influences antibody levels in
bronchoalveolar lavage fluid and disease outcome in experimentally infected calves. Vaccine 23:4625–4630.
Kita, H. 2011. Eosinophils: Multifaceted biological properties and
roles in health and disease. Immunol. Rev. 242:161–177.
Leach, R., S. Craigmile, S. Knott, J. Williams, and E. Glass. 2010.
Quantitative trait loci for variation in immune response to a
foot-and-mouth disease virus peptide. BMC Genet. 11:107.
Leach, R. J., R. G. O’Neill, J. L. Fitzpatrick, J. L. Williams, and E. J.
Glass. 2012. Quantitative trait loci associated with the immune
response to a bovine respiratory syncytial virus vaccine. PLoS
ONE 7:E33526.
McNeill, J. W., J. C. Paschal, M. S. McNeill, and W. W. Morgan.
1996. Effect of morbidity on performance and profitability of
feedlot steers. J. Anim. Sci. 74(Suppl. 1):135. (Abstr.)

White blood cell correlations to respiratory disease
Morris, C. A. 2007. A review of genetic resistance to disease in Bos
taurus cattle. Vet. J. 174:481–491.
Muggli-Cockett, N. E., L. V. Cundiff, and K. E. Gregory. 1992.
Genetic analysis of bovine respiratory disease in beef calves
during the first year of life. J. Anim. Sci. 70:2013–2019.
Paape, M. J., D. D. Bannerman, X. Zhao, and J. W. Lee. 2003. The
bovine neutrophil: Structure and function in blood and milk.
Vet. Res. 34:597–627.
Rabeling, B., J. Rehage, D. Dopfer, and H. Scholz. 1998.
Ultrasonographic findings in calves with respiratory disease.
Vet. Rec. 143:468–471.
Schneider, M. J., R. G. Tait Jr., W. D. Busby, and J. M. Reecy. 2009.
An evaluation of bovine respiratory disease complex in feedlot
cattle: Impact on performance and carcass traits using treatment
records and lung lesion scores. J. Anim. Sci. 87:1821–1827.
Schneider, M. J., R. G. Tait Jr., M. V. Ruble, W. D. Busby, and J.
M. Reecy. 2010. Evaluation of fixed sources of variation and
estimation of genetic parameters for incidence of bovine respiratory disease in preweaned calves and feedlot cattle. J. Anim.
Sci. 88:1220–1228.

3573

Snowder, G. D., L. D. Van Vleck, L. V. Cundiff, and G. L. Bennett.
2005. Influence of breed, heterozygosity, and disease incidence
on estimates of variance components of respiratory disease in
preweaned beef calves. J. Anim. Sci. 83:1247–1261.
Snowder, G. D., L. D. Van Vleck, L. V. Cundiff, and G. L. Bennett.
2006. Bovine respiratory disease in feedlot cattle: Environmental,
genetic, and economic factors. J. Anim. Sci. 84:1999–2008.
Thompson, P. N., A. Stone, and W. A. Schultheiss. 2006. Use of treatment records and lung lesion scoring to estimate the effect of
respiratory disease on growth during early and late finishing periods in South African feedlot cattle. J. Anim. Sci. 84:488–498.
Tizard, I. R. 2012. Veterinary immunology. 9th ed. Elsevier, W.B.
Saunders Co., Philadelphia, PA.
Werling, D., and T. W. Jungi. 2003. TOLL-like receptors linking innate and adaptive immune response. Vet. Immunol.
Immunopathol. 91:1–12.
Westell, R. A., R. L. Quaas, and L. D. Van Vleck. 1988. Genetic
groups in an animal model. J. Dairy Sci. 71:1310–1318.
Wittum, T. E., N. E. Woollen, L. J. Perino, and E. T. Littledike. 1996.
Relationships among treatment for respiratory tract disease,
pulmonary lesions evident at slaughter, and rate of weight gain
in feedlot cattle. J. Am. Vet. Med. Assoc. 209:814–818.

